General-purpose large language models (LLMs) that rely on in-context learning do not reliably deliver the scientific ...
Liquid AI and Insilico Medicine today announced a partnership that creates lightweight scientific foundation models for pharmaceutical research. The collaboration has produced LFM2-2.6B-MMAI (v0.2.1), ...
As drug prices continue to rise and the affordability of medicines for patients remains out of reach, finding new and creative solutions that address affordability, while also rewarding innovation, is ...
Single 2.6B-parameter model achieves state-of-the-art performance across drug discovery benchmarks while running entirely on private pharmaceutical infrastructure CAMBRIDGE, Mass., March 3, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results